Cargando…
Raltitrexed Inhibits HepG2 Cell Proliferation via G(0)/G(1) Cell Cycle Arrest
Raltitrexed (RTX) is an antimetabolite drug used as a chemotherapeutic agent for treating colorectal cancer, malignant mesothelioma, and gastric cancer. The antitumor capacity of RTX is attributed to its inhibitory activity on thymidylate synthase (TS), a key enzyme in the synthesis of DNA precursor...
Autores principales: | Zhao, Hongwei, Zhang, Yubao, Sun, Jianmin, Zhan, Chao, Zhao, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838684/ https://www.ncbi.nlm.nih.gov/pubmed/27098147 http://dx.doi.org/10.3727/096504016X14562725373671 |
Ejemplares similares
-
Digitoxin inhibits proliferation of multidrug-resistant HepG2 cells through G(2)/M cell cycle arrest and apoptosis
por: Lei, Yuhe, et al.
Publicado: (2020) -
Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells
por: Wang, Tianzhen, et al.
Publicado: (2011) -
Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells
por: Wang, Qing-Qing, et al.
Publicado: (2011) -
Downregulation of HBx Restrains Proliferation, Migration, and Invasion of HepG2 Cells
por: Huang, Chaoqun, et al.
Publicado: (2021) -
Crude extract and solvent fractions of Calystegia soldanella induce G1 and S phase arrest of the cell cycle in HepG2 cells
por: Lee, Jung Im, et al.
Publicado: (2017)